These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31306601)

  • 21. The influence of speaker and listener variables on intelligibility of dysarthric speech.
    Patel R; Usher N; Kember H; Russell S; Laures-Gore J
    J Commun Disord; 2014; 51():13-8. PubMed ID: 25113966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hybridizing conversational and clear speech to investigate the source of increased intelligibility in speakers with Parkinson's disease.
    Tjaden K; Kain A; Lam J
    J Speech Lang Hear Res; 2014 Aug; 57(4):1191-205. PubMed ID: 24686409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Speech Prosody Across Stimulus Types for Individuals with Parkinson's Disease.
    K-Y Ma J; Schneider CB; Hoffmann R; Storch A
    J Parkinsons Dis; 2015; 5(2):291-9. PubMed ID: 25697957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of clear, loud, and slow speech on scaled intelligibility and speech severity in Parkinson's disease and multiple sclerosis.
    Tjaden K; Sussman JE; Wilding GE
    J Speech Lang Hear Res; 2014 Jun; 57(3):779-92. PubMed ID: 24687042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acoustic and perceptual correlates of faster-than-habitual speech produced by speakers with Parkinson's disease and multiple sclerosis.
    Kuo C; Tjaden K; Sussman JE
    J Commun Disord; 2014; 52():156-69. PubMed ID: 25287378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rating the intelligibility of dysarthic speech amongst people with Parkinson's Disease: a comparison of trained and untrained listeners.
    Smith CH; Patel S; Woolley RL; Brady MC; Rick CE; Halfpenny R; Rontiris A; Knox-Smith L; Dowling F; Clarke CE; Au P; Ives N; Wheatley K; Sackley CM
    Clin Linguist Phon; 2019; 33(10-11):1063-1070. PubMed ID: 31035809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intelligibility of dysarthric speech: perceptions of speakers and listeners.
    Walshe M; Miller N; Leahy M; Murray A
    Int J Lang Commun Disord; 2008; 43(6):633-48. PubMed ID: 18608608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Cross-Language Study of Acoustic Predictors of Speech Intelligibility in Individuals With Parkinson's Disease.
    Kim Y; Choi Y
    J Speech Lang Hear Res; 2017 Sep; 60(9):2506-2518. PubMed ID: 28821018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perceptual measures of speech from individuals with Parkinson's disease and multiple sclerosis: intelligibility and beyond.
    Sussman JE; Tjaden K
    J Speech Lang Hear Res; 2012 Aug; 55(4):1208-19. PubMed ID: 22232396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Impact of Contrastive Stress on Vowel Acoustics and Intelligibility in Dysarthria.
    Connaghan KP; Patel R
    J Speech Lang Hear Res; 2017 Jan; 60(1):38-50. PubMed ID: 28114612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Word-level intelligibility after caudal zona incerta stimulation for Parkinson's disease.
    Johansson L; Möller S; Olofsson K; Linder J; Nordh E; Blomstedt P; van Doorn J; Karlsson F
    Acta Neurol Scand; 2014 Jul; 130(1):27-33. PubMed ID: 24341730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parkinson's disease and the effect of lexical factors on vowel articulation.
    Watson PJ; Munson B
    J Acoust Soc Am; 2008 Nov; 124(5):EL291-5. PubMed ID: 19045680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of intensive speech rate and intonation therapy on intelligibility in Parkinson's disease.
    Martens H; Van Nuffelen G; Dekens T; Hernández-Díaz Huici M; Kairuz Hernández-Díaz HA; De Letter M; De Bodt M
    J Commun Disord; 2015; 58():91-105. PubMed ID: 26519934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sentence-Level Movements in Parkinson's Disease: Loud, Clear, and Slow Speech.
    Kearney E; Giles R; Haworth B; Faloutsos P; Baljko M; Yunusova Y
    J Speech Lang Hear Res; 2017 Dec; 60(12):3426-3440. PubMed ID: 29209727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acoustic and intelligibility characteristics of sentence production in neurogenic speech disorders.
    Weismer G; Jeng JY; Laures JS; Kent RD; Kent JF
    Folia Phoniatr Logop; 2001; 53(1):1-18. PubMed ID: 11125256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acoustic variation during passage reading for speakers with dysarthria and healthy controls.
    Kuo C; Tjaden K
    J Commun Disord; 2016; 62():30-44. PubMed ID: 27219893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Picture Description in the Assessment of Connected Speech Intelligibility in Parkinson's Disease: A Pilot Study.
    Johansson IL; Samuelsson C; Müller N
    Folia Phoniatr Logop; 2022; 74(5):320-334. PubMed ID: 35021169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Examining the effects of multiple sclerosis on speech production: does phonetic structure matter?
    Rosen KM; Goozée JV; Murdoch BE
    J Commun Disord; 2008; 41(1):49-69. PubMed ID: 17509609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acoustic and perceptual speech characteristics of native Mandarin speakers with Parkinson's disease.
    Hsu SC; Jiao Y; McAuliffe MJ; Berisha V; Wu RM; Levy ES
    J Acoust Soc Am; 2017 Mar; 141(3):EL293. PubMed ID: 28372040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acoustic and Perceptual Consequences of Speech Cues for Mandarin Speakers With Parkinson's Disease.
    Hsu SC; McAuliffe MJ; Lin P; Wu RM; Levy ES
    Am J Speech Lang Pathol; 2019 May; 28(2):521-535. PubMed ID: 31136238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.